Home Business Opportunities Licensing of New Products/Technologies
Elisa Based Test for Aspergillus
 

-

Thetest kit with high sensitivity and specificity using well defined synthetic .

   

aspergillus fumigatus, candida albicans and cryptococcus neoformans cause a variety of clinical symptoms in human and animals. aspergillus fumigatus is the major causative agent of aspergelosis and induces hypersenstive reactions of type I and type III resulting in elevated levels of specific antibodies. Diagnostic value of specific antibodies to aspergillus fumigatus is well established in allergic bronchopulmonary aspergelosis, aspergilloma and early Aspergillus involvement in other clinical conditions.

-

Major clinical symptoms of aspergillosis include fleeting shadows in the lungs, pulmonary eosinophilia, fever and bronchospasm. These symptoms are often mistaken for tuberculosis and result in irreversible fibrotic change. Target groups for screening for aspergillosis include asthmatic, tuberculosis, post Kochs, leukemics, malignancies, HIV and thalassemics.

Other Products
-
Centbucridine
Centbutindole
Centpropazine
Picroliv
Bacopa Monnieri
Leishmaniasis
Opioid Peptide
Arteether
Isaptent
Centchroman
Gugulipid
-
-
-

IPR covered:

Country Details
1. US

Application no 09/184938 filed on March 11, 1998

2. European

Application No. 99309700.5-2204 filed on 02/12/99

3. India

Application Nos. 2996/DEL/95 filed on 29/12/1995

4. India

Application Nos. 746/DEL/98 filed on 09/11/1998

5. India

Application Nos. 751/DEL/98 filed on 24/03/1998

6. India

Application Nos. 752/DEL/98 filed on 24/03/1998

7. India

Application Nos. 754/DEL/98 filed on 24/03/1998

 
-
-
 

The Organisation
| Programme & Activities | Expertise Available | Achievements | Business Opportunities
| Career Opportunities

.